Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Early auditory information processing (EAP) measures serve as endophenotypes in genomic studies and biomarkers in clinical trials for schizophrenia.
• Previous research indicates correlations between EAP, cognition, clinical symptoms, and functional outcomes in schizophrenia.
• Understanding the pathways linking EAP deficits to functional outcomes is crucial for targeted therapeutic interventions.

Purpose of the Study:

• To elucidate the pathways connecting EAP to functional outcomes in individuals with schizophrenia.
• To quantify the potential impact of enhancing basic information processing on cognitive and psychosocial functioning.

Main Methods:

• A cross-sectional study analyzed data from 1415 outpatients with schizophrenia recruited from 5 sites (Consortium on the Genetics of Schizophrenia 2).
• Structural equation modeling was employed to examine associations among EAP, cognition, negative symptoms, and functional outcome.
• EAP was measured using mismatch negativity, P3a, and reorienting negativity; cognition by various tests; negative symptoms by the Scale for the Assessment of Negative Symptoms; and functional outcome by the Role Functioning Scale.

Main Results:

• EAP directly influenced cognition (β=0.37, P<.001).
• Cognition directly affected negative symptoms (β=-0.16, P<.001), and both cognition (β=0.26, P<.001) and negative symptoms (experiential: β=-0.75, P<.001) directly impacted functional outcome.
• A significant indirect effect of EAP on functional outcome was observed (β=0.14, P<.001), indicating a fully mediated pathway through cognition and negative symptoms.

Conclusions:

• The findings support a model where EAP deficits contribute to poor functional outcomes in schizophrenia via impaired cognition and increased negative symptoms.
• These results can inform the development of personalized, mechanistically-guided treatments for schizophrenia.
• EAP measures show promise as surrogate endpoints in early-stage procognitive intervention studies.